Infection and Immunity



Infection and Immunity






The ageing immune system

The immune system ages in a complex manner:



  • Some activities increase (eg production of memory T lymphocytes, IgA, and autoantibodies)


  • Other activities diminish (eg production of some interleukins, antibodies in response to foreign antigens, macrophage clearance of antigens, and complement during acute infection)


  • Overall, immune responses become less efficient, less appropriate, and occasionally harmful with age


  • The immune system does not wear out—it becomes dysfunctional


  • This is an insidious process, often unnoticed until times of physiological stress (eg acute illness)


  • It is more marked in older people with chronic disease, multiple comorbidities and significant genetic and environmental factors

This immune dysfunction alters the response to infection in older people:



  • Infectious disease is a more significant cause of morbidity and mortality in older people (up to 10 times more likely to be the cause of death)


  • Impaired cellular immunity predisposes older people to reactivation of certain diseases eg:



  • Altered antibody production increases fatality from pneumonia, influenza, bacterial endocarditis, and hospital-acquired infections


  • Decreased levels of lymphokines increase susceptibility to parasitic infections


  • Age-related immune dysfunction probably has a negative impact of the course of AIDS in older patients (see image ‘HIV in older people’, p.530)

Investigations may not show characteristic changes associated with infection, or these changes may develop more slowly (eg rise in white cell count, CRP, and complement).

It also has other clinical consequences:



  • Increased autoantibody production does not lead to an increase in autoimmune disease (this peaks in middle age), but may contribute to degenerative diseases


  • Response to vaccination may be less good


  • Falling immune surveillance may contribute to higher cancer incidence


  • T lymphocyte dysfunction may contribute to the increasing incidence of monoclonal gammopathy with age (see image ‘Paraproteinaemias’, p.459)


  • IgE-mediated hypersensitivity reactions are less frequent, so allergic symptoms tend to improve with age




Overview of infection in older people

Susceptibility to infection is increased by:


Blunted response to infection may occur in those with:



  • Decreased cardiac adaptation to stress


  • Comorbid conditions and frailty


  • Decreased lean body mass or malnutrition


  • Multiple previous hospital admissions or residence in a long-term care facility


Presentation



  • Frequently atypical eg global deterioration, non-specific functional decline, delirium, falls, incontinence


  • May initially give no clue to the site of sepsis, eg chest infections may present with falls, rather than cough


  • Fever is often absent, reduced, or delayed (due to senescent hypothalamic and other responses)


  • Often indolent with a slow deterioration over several days

By the time sepsis is obvious, the patient may be very unwell.


Investigation

Obtaining samples can be difficult, eg delirious uncooperative patient, urinary or faecal incontinence, inability to expectorate sputum, etc.

Misleading results are common:



  • Positive urine dipstick often does not indicate symptomatic infection (see image ‘Near-patient urine tests’, p.618)


  • Urine samples from a catheterized patient will usually be heavily colonized; dipstick tests will be positive and culture results difficult to interpret


  • Ulcers will usually be colonized and swab results should be interpreted with caution (see image ‘Leg ulcers’, p.593)


  • Abdominal ultrasound scan will often reveal gallstones in older patients—these are usually asymptomatic and do not necessarily imply biliary sepsis


  • Classical markers of infection (leucocytosis, elevated CRP, increased complement) may be absent or delayed in older patients. Repeating them after 24hr improves sensitivity




Antibiotic use in older patients

Antibiotics are among the most frequently prescribed drugs, and their widespread use is promoting increasing antibiotic resistance.

This is a particular problem in older patients where infections are more common, yet accurate diagnosis can be more difficult.


Antibiotic resistance

Resistance is encouraged by:



  • ‘Blind’ antibiotic therapy (where likely microbe and sensitivities are not known)


  • Inappropriate antibiotic therapy (eg for viral respiratory infections)


  • Inadequate treatment courses


  • Poor concordance with therapy


  • Transmission of resistant strains within healthcare settings


Sensible antibiotic prescribing

Helps to limit the problem. Applies to all ages, but may be more of a challenge in older patients:



  • Make a diagnosis—identify the source of sepsis (and so possible pathogens), which will guide therapy before microbiological confirmation is obtained


  • Avoid antibiotics for infections that are likely to be viral, eg pharyngitis, upper respiratory tract infection


  • Where practicable, send samples for culture and sensitivity before initiating antibiotics


  • Local variations (eg diagnostic mix, local sensitivities) should be considered. Use local antimicrobial guidelines


  • Choose the dose based on the patient (allergies, age, weight, kidney function, etc.) and the severity of the infection. Inadequate doses promote resistance


  • Choose the route—aim for oral wherever possible, and convert iv therapy to oral as soon as feasible; im antibiotic therapy is uncomfortable but can be useful (eg cognitively impaired patients who refuse oral medication)


  • Choose the duration based on the type of infection, eg simple UTI can be adequately treated in 3 days, whereas bacterial endocarditis can require many weeks of therapy. Unnecessarily long treatment courses will promote resistance, increase the risk of side effects, complications (eg CDAD) and increase cost


  • Change empirical broad-spectrum antibiotics to narrow-spectrum alternatives as soon as sensitivities are known



Further reading

British National Formulary (BNF) Section 5.1 Antibacterial drugs.



Meticillin-resistant Staphylococcus aureus

Meticillin was introduced in the 1960s to treat staphylococcal infections. It was used widely (including spraying solutions into the air on wards) and initially successfully. Meticillin has now been discontinued and replaced by flucloxacillin but the term MRSA persists.

Resistance to meticillin gradually emerged—firstly small numbers within hospitals, but the problem slowly increased and spread into the community, until globally dispersed epidemic strains emerged.

All staphylococci are easily transmissible, virulent (capacity to cause disease) and have capacity to develop further antibiotic resistance.


The problem today



  • Varies enormously eg > 25% of invasive Staph. aureus isolates are resistant in UK, Spain, and Italy, compared with <1% in Scandinavia


  • However, rates peaked in 2005/6 and are now reducing—deaths where MRSA was mentioned on death certificates have decreased from > 1600/year to <800/year between 2005 and 2009


  • MRSA reduction continues to be a political target in the UK


Contamination and transmission



  • Anything coming into contact with an MRSA source can become contaminated—ie MRSA will exist for a short time on that surface


  • Transient carriage on the gloves or hands of healthcare workers is likely to represent the main mode of transmission to other patients


  • Up to 35% of environmental surfaces in a room being used by an MRSA patient will culture positive (role in transmission is unclear)


  • Decontamination involves cleaning. Good hand hygiene and the use of alcohol hand gel after patient contact reduce transmission significantly


Colonization



  • This is asymptomatic carriage of MRSA. Patients and families often need reassurance that this rarely has implications for the patient


  • Common sites are anterior nares, perineum, hands, axillae, wounds, ulcers, sputum, throat, urine, venous access sites and catheters


  • Duration of colonization varies from days to years


  • Transmission from a colonized person is more likely if there is a heavy bacterial load with abnormal skin (eg ulcers, eczema), devices (eg catheters, cannulae) or sinusitis/respiratory tract infection


  • Many healthcare workers are colonized (usually nasal) and are a potential reservoir, but usually colonization is short lived so that screening healthcare workers is only useful for investigating specific outbreaks


  • Screening for MRSA colonization is now routine practice prior to elective procedures and for most hospital admissions especially interhospital transfers. Eradication of MRSA may follow; treatment regimens include the application of nasal mupirocin, antimicrobial soaps and sometimes oral antibiotics (eg fusidic acid, rifampicin)



Further reading

Office of National Statistics online: image www.statistics.gov.uk.



Disease caused by MRSA

The most common sites of infection are:



  • Wounds—most common cause of postoperative wound infections


  • Intravenous lines—often leading to bacteraemia


  • Ulcers—including pressure, diabetic, and venous ulcers


  • Deep abscesses—infection can seed to many sites, eg lungs, kidneys, bones, liver, and spleen


  • Bacteraemia—there is compulsory reporting

30-60% of hospital patients colonized with MRSA will go on to develop infection. This is more likely if there has been:

Jul 22, 2016 | Posted by in GERIATRICS | Comments Off on Infection and Immunity

Full access? Get Clinical Tree

Get Clinical Tree app for offline access